PGNY logo

PROGYNY INC

PGNYNASDAQ
🏆 #2003 by market capEarnings Oct 29US Equity
$806.36▼ $59.19 (−7.34%)
Simulated price
🔔
Track PGNY
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 7.3%
7d▲ 2973.0%
14d▲ 2803.7%
30d▲ 3001.4%
ytd▲ 3038.8%
1y▲ 3664.5%
🏦Market Cap
$2.00B
Small Cap
📈Revenue Growth (YoY)
+10.4%
Healthy
📊Gross Margin
24.6%
Moderate
💵FCF Margin
16.6%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
72
Fair

Trading Snapshot

Day Range
$801.45 – $813.34
52-Week Range
$16.10 – $33.07
Volume
$2.59B
Avg Volume
$3.22B
Shares Outstanding
78.3M
Next Earnings
Nov 12, 2026

Fundamentals Snapshot

Annual Revenue
$1.29B
Last Q Revenue
$351M
P/E Ratio
26.3
P/S Ratio
1.5x
EPS (TTM)
$1.01
Dividend Yield
0.00%
Dilution (1yr)
−6.3%

Why Investors Own PGNY

  • ✓High-growth profile — revenue up -7.4% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 76% gross margin and 27% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

PGNY logo

PROGYNY INC

PGNY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.3B▲ +10.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
23.6%▲ +8.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$85M▲ +26.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$192M▲ +10.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
89.5M▼ −6.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$85M▼ −$59M YoY
StockOtter · stockotter.space

About PROGYNY INC

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100

Analyst Price Target

ⓘ
Average Target
$797.14
▼ −1.1% Downside
High Target$985.34
Low Target$659.42
Based on 33 analysts

Latest News & Updates

🚀
CNBC·2h ago

PROGYNY INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift PGNY price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

PROGYNY INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.